关注
Warren Mason
Warren Mason
Princess Margaret Cancer Centre, University of Toronto
在 uhn.ca 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp, WP Mason, MJ Van Den Bent, M Weller, B Fisher, ...
New England journal of medicine 352 (10), 987-996, 2005
225612005
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
ME Hegi, AC Diserens, T Gorlia, MF Hamou, N De Tribolet, M Weller, ...
New England Journal of Medicine 352 (10), 997-1003, 2005
84472005
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the …
R Stupp, ME Hegi, WP Mason, MJ Van Den Bent, MJB Taphoorn, ...
The lancet oncology 10 (5), 459-466, 2009
81302009
Paraneoplastic anti–NmethylDaspartate receptor encephalitis associated with ovarian teratoma
J Dalmau, E Tüzün, H Wu, J Masjuan, JE Rossi, A Voloschin, ...
Annals of neurology 61 (1), 25-36, 2007
30672007
Bevacizumab plus radiotherapy–temozolomide for newly diagnosed glioblastoma
OL Chinot, W Wick, W Mason, R Henriksson, F Saran, R Nishikawa, ...
New England Journal of Medicine 370 (8), 709-722, 2014
26652014
European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and …
R Stupp, WP Mason, MJ Van den Bent, M Weller, B Fisher, MJ Taphoorn, ...
N Engl J Med 352 (10), 987-996, 2005
1924*2005
Short-course radiation plus temozolomide in elderly patients with glioblastoma
JR Perry, N Laperriere, CJ O’Callaghan, AA Brandes, J Menten, C Phillips, ...
New England Journal of Medicine 376 (11), 1027-1037, 2017
10282017
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma
R Vitaliani, W Mason, B Ances, T Zwerdling, Z Jiang, J Dalmau
Annals of Neurology: Official Journal of the American Neurological …, 2005
8052005
Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of …
M Petit-Pedrol, T Armangue, X Peng, L Bataller, T Cellucci, R Davis, ...
The lancet neurology 13 (3), 276-286, 2014
6382014
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
RO Mirimanoff, T Gorlia, W Mason, MJ Van den Bent, RD Kortmann, ...
Journal of clinical oncology 24 (16), 2563-2569, 2006
6272006
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma
TT Batchelor, P Mulholland, B Neyns, LB Nabors, M Campone, A Wick, ...
Journal of Clinical Oncology 31 (26), 3212-3218, 2013
5962013
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma
W Wick, VK Puduvalli, MC Chamberlain, MJ Van Den Bent, AF Carpentier, ...
Journal of clinical oncology 28 (7), 1168-1174, 2010
5702010
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
BG Baumert, ME Hegi, MJ van den Bent, A von Deimling, T Gorlia, ...
The Lancet Oncology 17 (11), 1521-1532, 2016
4892016
Changing paradigms—an update on the multidisciplinary management of malignant glioma
R Stupp, ME Hegi, MJ Van Den Bent, WP Mason, M Weller, ...
The oncologist 11 (2), 165-180, 2006
4872006
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
F Graus, J Dalmou, R Rene, M Tora, N Malats, JJ Verschuuren, ...
Journal of Clinical Oncology 15 (8), 2866-2872, 1997
4511997
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study
JR Perry, K Bélanger, WP Mason, D Fulton, P Kavan, J Easaw, C Shields, ...
Journal of clinical oncology 28 (12), 2051-2057, 2010
4252010
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
WP Mason, F Graus, B Lang, J Honnorat, JY Delattre, F Valldeoriola, ...
Brain: a journal of neurology 120 (8), 1279-1300, 1997
3961997
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3 …
MJ van den Bent, B Baumert, SC Erridge, MA Vogelbaum, AK Nowak, ...
The Lancet 390 (10103), 1645-1653, 2017
3702017
Health-related quality of life in patients with glioblastoma: a randomised controlled trial
MJB Taphoorn, R Stupp, C Coens, D Osoba, R Kortmann, ...
The lancet oncology 6 (12), 937-944, 2005
3652005
Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors
I Krop, T Demuth, T Guthrie, PY Wen, WP Mason, P Chinnaiyan, ...
Journal of clinical oncology 30 (19), 2307-2313, 2012
3492012
系统目前无法执行此操作,请稍后再试。
文章 1–20